Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
C-MER Medical (03309.HK) repurchased 60,000 shares for HK$45,000 on October 12.
12/10/2026
C-MER Medical (03309.HK) announced that on October 12, 2026, it spent HK$45,000 to repurchase 60,000 shares.
Latest
1 m ago
Lin Qingxuan (02657.HK) spent HKD 9.3637 million on October 12 to repurchase 154,100 shares.
1 m ago
Tencent Holdings (00700.HK) repurchased 235,000 shares for HK$100 million on October 12.
2 m ago
Tenfu (06868.HK) repurchased 5,000 shares for HK$12,900 on October 12.
2 m ago
Gan & Lee Pharmaceuticals (603087.SH): First subject dosed in Phase I clinical trial of GLR1075 injection
2 m ago
Shuanglu Pharmaceutical (002038.SZ) obtained the drug registration certificate for Ibrutinib Capsules.
See all latest